ashg logo  

Media Contact:
Nalini Padmanabhan

ASHG Communications Manager

301.634.7346

press@ashg.org

 

For Immediate Release

Wednesday, December 7, 2016

2:45 pm U.S. Eastern Time

 

ASHG Supports Genetic Privacy Provisions in 21st Century Cures Act

 

BETHESDA, MD – The American Society of Human Genetics (ASHG) commends Congress for strengthening privacy protections for genetics research participants as part of the 21st Century Cures Act (H.R.34) passed on December 7. These provisions, Section 2012 and Section 2013 of H.R.34, were originally introduced in the Senate by Senator Warren (D-MA) and Senator Enzi (R-WY) as the Genetic Research Privacy Protection Act (S.2744), legislation endorsed by ASHG.

 

“Remarkable innovation in DNA sequencing technologies means that we can now conduct genomics research on a completely different scale from only a few years ago, resulting in large-scale programs like the Precision Medicine Initiative, which will include the analysis of the genomes of more than a million participants,” said Derek Scholes, PhD, Director of Science Policy at ASHG. “In launching such research projects, it is important to protect the privacy of participants, who, in volunteering to participate, entrust researchers with their private, sensitive information.”

 

Some of the newly passed protections build on existing certificates of confidentiality protections for research participants. These certificates allow research institutions to reject requests for individuals’ research data from people or entities not involved in the research. Currently, researchers may request these certificates but are not under any obligation to do so. Under the new law, certificates of confidentiality will be issued automatically for research projects involving the collection of identifiable, sensitive research information.

 

In addition, the new provisions guard against inappropriate use of the Freedom of Information Act (FOIA) to gain access to participants’ genetic and health information by allowing the Department of Health and Human Services to explicitly disqualify such individual-level research data from FOIA.

 

“With improved protections, individuals can participate in research with increased confidence that their genetic and health information will remain private,” said Hal Dietz, MD, President of ASHG. “The Society applauds the leadership of Senator Warren and Senator Enzi in establishing these protections.”

 

References:

 

ASHG. Letter of support for Genetic Research Privacy Protection Act (S.2744). (2016 Jun 24).

 

114th Congress (2015-16). H.R.34 – 21st Century Cures Act. (latest action 2016 Dec 6).

 

* * *

 

About the American Society of Human Genetics (ASHG)

Founded in 1948, the American Society of Human Genetics is the primary professional membership organization for human genetics specialists worldwide. Its nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others with an interest in human genetics. The Society serves scientists, health professionals, and the public by providing forums to: (1) share research results through the ASHG Annual Meeting and in The American Journal of Human Genetics; (2) advance genetic research by advocating for research support; (3) educate current and future genetics professionals, health care providers, advocates, policymakers, educators, students, and the public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information, visit: http://www.ashg.org.

 

9650 Rockville Pike | Bethesda, MD 20814 | 301.634.7300 | society@ashg.org | www.ashg.org

Connect with ASHG on Twitter (@GeneticsSociety) | Facebook | LinkedIn